A detailed history of Essex Investment Management CO LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Essex Investment Management CO LLC holds 697 shares of HAE stock, worth $63,252. This represents 0.01% of its overall portfolio holdings.

Number of Shares
697
Previous 697 -0.0%
Holding current value
$63,252
Previous $57,000 1.75%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$81.24 - $97.37 $7,799 - $9,347
-96 Reduced 12.11%
697 $57,000
Q1 2024

May 03, 2024

SELL
$71.24 - $85.35 $22,725 - $27,226
-319 Reduced 28.69%
793 $67,000
Q4 2023

Feb 07, 2024

SELL
$80.59 - $92.61 $813,636 - $934,990
-10,096 Reduced 90.08%
1,112 $95,000
Q3 2023

Nov 09, 2023

BUY
$82.56 - $93.49 $99,732 - $112,935
1,208 Added 12.08%
11,208 $1 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $808,400 - $894,500
10,000 New
10,000 $851,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.66B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.